G1 Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. G1 Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 61% to $82,511,000. The net income raised on -$47,967,000 and profit margin reached -58%. Total operating expenses were $114,843,000.
Profit Margin
| 2014 | 1.04M | -7.18M | -688.64% |
|---|---|---|---|
| 2015 | 522K | -20.26M | -3881.8% |
| 2016 | 0 | -30.29M | |
| 2017 | 0 | -60.12M | |
| 2018 | 0 | -85.28M | |
| 2019 | 0 | -122.09M | |
| 2020 | 45.28M | -99.25M | -219.18% |
| 2021 | 31.47M | -148.35M | -471.32% |
| 2022 | 51.30M | -147.55M | -287.63% |
| 2023 | 82.51M | -47.96M | -58.13% |
GTHX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 82.51M | 51.30M | 31.47M | 45.28M | 0 | 0 | 0 | 0 | 522K | 1.04M |
Cost of revenue | 7.19M | 3.74M | 2.01M | 0 | 356K | 0 | 89K | 0 | 12.73M | 5.01M |
Gross profit | 75.31M | 47.55M | 29.46M | 45.28M | -356K | 0 | -89K | 0 | -12.20M | -3.97M |
Operating exp. | ||||||||||
Research and development | 43.71M | 83.31M | 76.22M | 73.27M | 89.00M | 70.68M | 53.88M | 25.16M | 12.73M | 5.01M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 114.84M | 183.73M | 171.91M | 141.76M | 129.04M | 89.28M | 60.96M | 30.39M | 15.94M | 2.70M |
Operating income | -39.52M | -136.17M | -142.45M | -96.47M | -129.04M | -89.28M | -60.96M | -30.39M | -15.42M | -6.67M |
Other income (expenses), net | -5.32M | -9.68M | -4.97M | -1.36M | 6.59M | 3.99M | 847K | 100.14K | -4.83M | -64 |
Income before tax | -44.85M | -145.85M | -147.42M | -97.84M | -122.44M | -85.28M | -60.12M | -30.29M | -20.26M | -6.67M |
Income tax expense | 3.11M | 1.7M | 925K | 1.41M | -356K | 3.99M | 41K | 82.23K | 4.85M | 502.36K |
Net income | -47.96M | -147.55M | -148.35M | -99.25M | -122.09M | -85.28M | -60.12M | -30.29M | -20.26M | -7.18M |
Earnings per share | ||||||||||
Basic EPS | -0.93 | -3.38 | -3.54 | -2.62 | -3.26 | -2.56 | -3.3 | -1.48 | -0.99 | -5.85 |
Diluted EPS | -0.93 | -3.38 | -3.54 | -2.62 | -3.26 | -2.56 | -3.3 | -1.48 | -0.99 | -5.85 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |